Allurion stock surges 70% on weight-loss therapy update (Alur: NYSE)


Obesity card in doctor's hands

Mikhail_petrov-96

Allurion shares (NYSE:channel) surged 70% in after-market trading Thursday after ending the regular session up 21% on news that the company plans to conduct a clinical study of its gastric balloon weight loss product in combination with LPG drugs -1.

Allurion (



Source link

  • Related Posts

    French Services contracts further in January, PMI shows reuters

    Paris (Reuters) – The Services Services in France is added in January while businesses face weak demand and no withdrawal politics in the S & P worldwide published on Friday.…

    Rivian says other automakers are “knocking on the door” about the VW joint venture’s technology

    By Abhirup Roy PALO ALTO, Calif. (Reuters) – A joint venture between U.S. electric pickup and SUV maker Rivian and Volkswagen is in talks with other automakers about supplying its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *